Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative Infections
Infection and Drug Resistance · 2026-04 · Volume 19 · 1-22
DOI: 10.2147/idr.s541581 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infection and Drug Resistance, 2026-04. Verfasst von Monica Melchio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Health Sciences, University of Genova, Genova, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Health Sciences, University of Genova, Genova, Italy.
- Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Zitieren
APA
Melchio, M., Briano, F., Sepulcri, C., Vena, A., & Bassetti, M. (2026). Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative Infections. Infection and Drug Resistance, Volume 19, 1-22. https://doi.org/10.2147/idr.s541581
Vancouver
Melchio M, Briano F, Sepulcri C, Vena A, Bassetti M. Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative Infections. Infection and Drug Resistance. 2026;Volume 19:1-22. doi:10.2147/idr.s541581
BibTeX
@article{Melchio2026,
author = {Melchio, Monica and Briano, Federica and Sepulcri, Chiara and Vena, Antonio and Bassetti, Matteo},
title = {Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative Infections},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--22},
doi = {10.2147/idr.s541581}
}
EUVIMED